 |
The Journal of Neuroscience, May 16, 2007, 27(20):5394-5404; doi:10.1523/JNEUROSCI.5047-06.2007
Previous Article | Next Article 
Neurobiology of Disease
Connecting TNF- Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid ß Protein
Rodrigo Medeiros,1 *
Rui D. S. Prediger,1 *
Giselle F. Passos,1
Pablo Pandolfo,1
Filipe S. Duarte,1
Jeferson L. Franco,2
Alcir L. Dafre,2
Gabriella Di Giunta,3
Cláudia P. Figueiredo,3
Reinaldo N. Takahashi,1
Maria M. Campos,4 and
João B. Calixto1
Departamentos de 1Farmacologia and 2Ciências Fisiológicas, Centro de Ciências Biológicas, and 3Departamento de Anatomia Patológica, Hospital UniversitárioUniversidade Federal de Santa Catarina, 88049-900, Florianópolis, Santa Catarina, Brazil, and 4Faculdade de Odontologia, Pontifícia Universidade Católica do Rio Grande do Sul 90619-900, Rio Grande do Sul, Brazil
Correspondence should be addressed to Dr. João B. Calixto, Departamento de Farmacologia, Universidade Federal de Santa Catarina, Campus Universitário, Trindade, Bloco D, Caixa Postal 476, 88049-900, Florianópolis, Santa Catarina, Brazil. Email: calixto{at}farmaco.ufsc.br or Email: calixto3{at}terra.com.br
Increased brain deposition of amyloid ß protein (Aß) and cognitive deficits are classical signals of Alzheimer's disease (AD) that have been highly associated with inflammatory alterations. The present work was designed to determine the correlation between tumor necrosis factor- (TNF- )-related signaling pathways and inducible nitric oxide synthase (iNOS) expression in a mouse model of AD, by means of both in vivo and in vitro approaches. The intracerebroventricular injection of Aß140 in mice resulted in marked deficits of learning and memory, according to assessment in the water maze paradigm. This cognition impairment seems to be related to synapse dysfunction and glial cell activation. The pharmacological blockage of either TNF- or iNOS reduced the cognitive deficit evoked by Aß140 in mice. Similar results were obtained in TNF- receptor 1 and iNOS knock-out mice. Aß140 administration induced an increase in TNF- expression and oxidative alterations in prefrontal cortex and hippocampus. Likewise, Aß140 led to activation of both JNK (c-Jun-NH2-terminal kinase)/c-Jun and nuclear factor- B, resulting in iNOS upregulation in both brain structures. The anti-TNF- antibody reduced all of the molecular and biochemical alterations promoted by Aß140. These results provide new insights in mouse models of AD, revealing TNF- and iNOS as central mediators of Aß action. These pathways might be targeted for AD drug development.
Key words: Alzheimer's disease; amyloid ß; inflammation; TNF- ; iNOS; cognitive deficits
Received Nov. 21, 2006;
revised April 14, 2007;
accepted April 17, 2007.
Correspondence should be addressed to Dr. João B. Calixto, Departamento de Farmacologia, Universidade Federal de Santa Catarina, Campus Universitário, Trindade, Bloco D, Caixa Postal 476, 88049-900, Florianópolis, Santa Catarina, Brazil. Email: calixto{at}farmaco.ufsc.br or Email: calixto3{at}terra.com.br
This article has been cited by other articles:

|
 |

|
 |
 
P. Lu, T. Mamiya, L. L. Lu, A. Mouri, M. Niwa, M. Hiramatsu, L. B. Zou, T. Nagai, T. Ikejima, and T. Nabeshima
Silibinin Attenuates Amyloid {beta}25-35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor-{alpha} in Mice
J. Pharmacol. Exp. Ther.,
October 1, 2009;
331(1):
319 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Passos, C. P. Figueiredo, R. D. S. Prediger, P. Pandolfo, F. S. Duarte, R. Medeiros, and J. B. Calixto
Role of the Macrophage Inflammatory Protein-1{alpha}/CC Chemokine Receptor 5 Signaling Pathway in the Neuroinflammatory Response and Cognitive Deficits Induced by {beta}-Amyloid Peptide
Am. J. Pathol.,
October 1, 2009;
175(4):
1586 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gorlovoy, S. Larionov, T. T. H. Pham, and H. Neumann
Accumulation of tau induced in neurites by microglial proinflammatory mediators
FASEB J,
August 1, 2009;
23(8):
2502 - 2513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cheret, A. Gervais, A. Lelli, C. Colin, L. Amar, P. Ravassard, J. Mallet, A. Cumano, K.-H. Krause, and M. Mallat
Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase
J. Neurosci.,
November 12, 2008;
28(46):
12039 - 12051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jimenez, D. Baglietto-Vargas, C. Caballero, I. Moreno-Gonzalez, M. Torres, R. Sanchez-Varo, D. Ruano, M. Vizuete, A. Gutierrez, and J. Vitorica
Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic
J. Neurosci.,
November 5, 2008;
28(45):
11650 - 11661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. M. Quintao, G. F. Passos, R. Medeiros, A. F. Paszcuk, F. L. Motta, J. B. Pesquero, M. M. Campos, and J. B. Calixto
Neuropathic Pain-Like Behavior after Brachial Plexus Avulsion in Mice: The Relevance of Kinin B1 and B2 Receptors
J. Neurosci.,
March 12, 2008;
28(11):
2856 - 2863.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|